Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 34171950!ä!34171950 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Vnitr+Lek 2021 ; 67 (E-3): 35-40 Nephropedia Template TP {{tp|p=34171950|t=2021. Zkušenost s peči o pacienty s covidem-19 ve Velke Britanii |pdf=|usr=}}{{34171950}} gab.com Text Zkušenost s peči o pacienty s covidem-19 ve Velke Britanii JO: Vnitr Lek http://www.kidney.de/pget.php?&tw=1&pmid=34171950 #FOAvip In response to the COVID-19 pandemic many health care systems have attempted to reorganize healthcare workforce. Many doctors and nurses have been redeployed to acute care wards. In order to ensure the best quality of care it is essential for health professionals to stay updated on clinical studies and novel therapeutical approaches. Most patients with COVID-19 who become seriously unwell have an acute respiratory illness and about 14 % will require non-invasive respiratory support. This article aims at presenting some of the approaches in respiratory support and drug therapy. The overview of management is based on current guidelines and conclusions of several studies. The author is aware of the fact that the approach in COVID-19 management may change over time based on the current state of knowledge. It is worth mentioning that regardless its severity clinical symptoms associated with COVID-19 pneumonia may only be minor and thus regular monitoring on standard wards is required. The article refers to recent studies related to dexamethasone and remdesivir. The treatment with interleukin-6 receptor antagonists is also discussed. Finally, other drugs in treatment of COVID-19 patients are mentioned. Twit Text FOAVip Zkušenost s peči o pacienty s covidem-19 ve Velke Britanii ????Vnitr Lek http://www.kidney.de/pget.php?&tw=1&pmid=34171950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34171950 #FOAvip English Wikipedia <ref>{{Cite pmid|34171950}}</ref> Zkušenost s peči o pacienty s covidem-19 ve Velke Britanii #MMPMID34171950 Aldhoon B Vnitr Lek 2021[Sum]; 67 (E-3): 35-40 PMID34171950show ga In response to the COVID-19 pandemic many health care systems have attempted to reorganize healthcare workforce. Many doctors and nurses have been redeployed to acute care wards. In order to ensure the best quality of care it is essential for health professionals to stay updated on clinical studies and novel therapeutical approaches. Most patients with COVID-19 who become seriously unwell have an acute respiratory illness and about 14 % will require non-invasive respiratory support. This article aims at presenting some of the approaches in respiratory support and drug therapy. The overview of management is based on current guidelines and conclusions of several studies. The author is aware of the fact that the approach in COVID-19 management may change over time based on the current state of knowledge. It is worth mentioning that regardless its severity clinical symptoms associated with COVID-19 pneumonia may only be minor and thus regular monitoring on standard wards is required. The article refers to recent studies related to dexamethasone and remdesivir. The treatment with interleukin-6 receptor antagonists is also discussed. Finally, other drugs in treatment of COVID-19 patients are mentioned. |*COVID-19[MESH] |*Pandemics[MESH] |Critical Care[MESH] |Humans[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH]Zkušenost s peči o pacienty s covidem-19 ve Velke Britanii (epmc).pdf DeepDyve Pubget Overpricing